Fertiprotekt: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Fertiprotekt}} | |||
[[File:Fertiprotekt_Logo_2014.png|thumb|right|Logo of Fertiprotekt]] | |||
'''Fertiprotekt''' is a network of centers in [[Europe]] dedicated to the preservation of [[fertility]] in patients undergoing medical treatments that may impair reproductive function. The network focuses on providing information, support, and treatment options to preserve fertility in patients facing [[cancer]] therapies, autoimmune diseases, and other conditions that may affect reproductive health. | |||
== | ==History== | ||
Fertiprotekt | Fertiprotekt was established in 2006 in response to the growing need for fertility preservation options for patients undergoing [[chemotherapy]] and [[radiation therapy]]. The network was founded by a group of reproductive medicine specialists and oncologists who recognized the impact of cancer treatments on fertility and sought to provide solutions to mitigate these effects. | ||
==Objectives== | |||
The primary objectives of Fertiprotekt include: | |||
* | * Providing comprehensive information on fertility preservation options to patients and healthcare providers. | ||
* Developing and promoting standardized protocols for fertility preservation. | |||
* Facilitating collaboration and research among member centers to advance the field of fertility preservation. | |||
* Raising awareness about the importance of fertility preservation in the context of cancer and other medical treatments. | |||
==Fertility Preservation Techniques== | |||
Fertiprotekt offers a range of fertility preservation techniques, including: | |||
* [[Oocyte cryopreservation]]: The process of freezing and storing [[oocytes]] (eggs) for future use. | |||
* [[Sperm cryopreservation]]: The freezing and storage of [[sperm]] for future use. | |||
* [[Embryo cryopreservation]]: The freezing and storage of [[embryos]] created through [[in vitro fertilization]] (IVF). | |||
* [[Ovarian tissue cryopreservation]]: The removal and freezing of ovarian tissue for later reimplantation. | |||
* [[Testicular tissue cryopreservation]]: The removal and freezing of testicular tissue, particularly for prepubescent boys who cannot produce sperm. | |||
== | ==Network Structure== | ||
Fertiprotekt is composed of a network of clinics and hospitals across Europe, each offering specialized services in fertility preservation. The network facilitates communication and collaboration among its members, allowing for the sharing of best practices and research findings. | |||
==Impact== | |||
Since its inception, Fertiprotekt has played a significant role in advancing the field of fertility preservation. The network has contributed to the development of new techniques and protocols, improving the success rates of fertility preservation methods. It has also increased awareness among healthcare providers and patients about the importance of considering fertility preservation as part of cancer treatment planning. | |||
==Related pages== | |||
* [[Fertility preservation]] | |||
* [[Oncofertility]] | * [[Oncofertility]] | ||
* [[ | * [[Cryopreservation]] | ||
* [[ | * [[Reproductive endocrinology]] | ||
[[Category:Fertility]] | [[Category:Fertility]] | ||
[[Category:Medical | [[Category:Medical organizations]] | ||
[[Category: | [[Category:Oncology]] | ||
Latest revision as of 11:51, 15 February 2025

Fertiprotekt is a network of centers in Europe dedicated to the preservation of fertility in patients undergoing medical treatments that may impair reproductive function. The network focuses on providing information, support, and treatment options to preserve fertility in patients facing cancer therapies, autoimmune diseases, and other conditions that may affect reproductive health.
History[edit]
Fertiprotekt was established in 2006 in response to the growing need for fertility preservation options for patients undergoing chemotherapy and radiation therapy. The network was founded by a group of reproductive medicine specialists and oncologists who recognized the impact of cancer treatments on fertility and sought to provide solutions to mitigate these effects.
Objectives[edit]
The primary objectives of Fertiprotekt include:
- Providing comprehensive information on fertility preservation options to patients and healthcare providers.
- Developing and promoting standardized protocols for fertility preservation.
- Facilitating collaboration and research among member centers to advance the field of fertility preservation.
- Raising awareness about the importance of fertility preservation in the context of cancer and other medical treatments.
Fertility Preservation Techniques[edit]
Fertiprotekt offers a range of fertility preservation techniques, including:
- Oocyte cryopreservation: The process of freezing and storing oocytes (eggs) for future use.
- Sperm cryopreservation: The freezing and storage of sperm for future use.
- Embryo cryopreservation: The freezing and storage of embryos created through in vitro fertilization (IVF).
- Ovarian tissue cryopreservation: The removal and freezing of ovarian tissue for later reimplantation.
- Testicular tissue cryopreservation: The removal and freezing of testicular tissue, particularly for prepubescent boys who cannot produce sperm.
Network Structure[edit]
Fertiprotekt is composed of a network of clinics and hospitals across Europe, each offering specialized services in fertility preservation. The network facilitates communication and collaboration among its members, allowing for the sharing of best practices and research findings.
Impact[edit]
Since its inception, Fertiprotekt has played a significant role in advancing the field of fertility preservation. The network has contributed to the development of new techniques and protocols, improving the success rates of fertility preservation methods. It has also increased awareness among healthcare providers and patients about the importance of considering fertility preservation as part of cancer treatment planning.